Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $23,224 - $26,723
-100 Reduced 18.45%
442 $108 Million
Q3 2022

May 28, 2024

SELL
$51.03 - $264.23 $22,555 - $116,789
-442 Closed
0 $0
Q2 2022

May 28, 2024

SELL
$234.74 - $275.42 $10,563 - $12,393
-45 Reduced 9.24%
442 $108,000
Q1 2022

May 28, 2024

BUY
$243.64 - $270.48 $118,652 - $131,723
487 New
487 $126,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $23,008 - $25,094
100 Added 22.62%
542 $136,000
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $2,327 - $2,564
10 Added 2.31%
442 $106,000
Q2 2020

Aug 20, 2020

BUY
$219.9 - $263.41 $94,996 - $113,793
432 New
432 $103,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Rockbridge Investment Management, Lcc Portfolio

Follow Rockbridge Investment Management, Lcc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

News

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.